Product
Remdesivir + Baricitinib
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized PatientsStatus: Active (not recruiting), Estimated PCD: 2024-04-01
1 clinical trial
1 indication